An update on the safety of psychostimulants for the treatment of attention-deficit/hyperactivity disorder
Open accessThe DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Methylphenidate is the first-line pharmacological treatment of attention-deficit/hyperactivity disorder (ADHD). Although methylphenidate has a well-established evidence base for treating ADHD, its long-term benefits are unclear. Areas covered: Physical adverse effects, psychiatric adverse events and brain development Expert opinion: Some physical adverse events have been described (e.g. sleep disturbances, growth reduction, loss of appetite), although most are of transient nature. Psychiatric adverse events seem more related to the diagnosis ADHD itself, and not stimulant treatment. Concluding, short-to-mid-term use (i.e., up to 2 years) stimulants are relatively safe, but much less is known about longer-term efficacy and safety of these drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Polanczyk, G. V., Salum, G. A., Sugaya, L. S., Caye, A., & Rohde, L. A. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12381 · Cited by 3,990 · cited 1×
“ADHD affects around 3% to 4% of children and adolescents [2] and often continues into adulthood [3] with rates in adulthood varying around 2.”
BackgroundPrevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis
Simon, V., Czobor, P., Bálint, S., Mészáros, Á., & Bitter, I. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.048827 · Cited by 1,601
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082 · cited 1×
“substance use disorders (SUDs) in ADHD [74].”
Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Nakao, T., Radua, J., Rubia, K., & Mataix-Cols, D. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020281 · Cited by 588
van Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.007 · Cited by 535
Frodl, T., & Skokauskas, N. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01786.x · Cited by 530 · cited 1×
“nantly medication-naive individuals were included compared to when more previously treated individuals were included [94,95].”
BackgroundTreatment of ADHD in children with tics: A randomized controlled trial
The Tourette’s Syndrome Study Group (2002) · Neurology · doi:10.1212/wnl.58.4.527 · Cited by 504
Charach, A., Yeung, E., Climans, T., & Lillie, E. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.09.019 · Cited by 482
Lambert, N. M., & Hartsough, C. S. (1998) · Journal of Learning Disabilities · doi:10.1177/002221949803100603 · Cited by 465
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
Cooper, W. O., Habel, L. A., Sox, C. M., Chan, K. A., Arbogast, P. G., Cheetham, T. C., Murray, K. T., Quinn, V. P., Stein, C. M., Callahan, S. T., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110212 · Cited by 411
Rubia, K., Halari, R., Cubillo, A., Mohammad, A.-M., Brammer, M., & Taylor, E. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.013 · Cited by 393
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374
Van der Oord, S., Prins, P. J. M., Oosterlaan, J., & Emmelkamp, P. M. G. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.10.007 · Cited by 336
Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up
SWANSON, J. M., ELLIOTT, G. R., GREENHILL, L. L., WIGAL, T., ARNOLD, L. E., VITIELLO, B., HECHTMAN, L., EPSTEIN, J. N., PELHAM, W. E., ABIKOFF, H. B., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180686d7e · Cited by 323 · cited 1×
“Although effects on growth have generally been minor [16], large variability in those affected has been described [17].”
BackgroundTeicher, M. H., Anderson, C. M., Polcari, A., Glod, C. A., Maas, L. C., & Renshaw, P. F. (2000) · Nature Medicine · doi:10.1038/74737 · Cited by 316
ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
Habel, L. A., Cooper, W. O., Sox, C. M., Chan, K. A., Fireman, B. H., Arbogast, P. G., Cheetham, T. C., Quinn, V. P., Dublin, S., Boudreau, D. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1830 · Cited by 297 · cited 1×
“33 years of current use in adults [21,29] pointed to encouraging safety with respect to the short- and medium-term use of stimulants.”
BackgroundHiscock, H., Sciberras, E., Mensah, F., Gerner, B., Efron, D., Khano, S., & Oberklaid, F. (2015) · BMJ · doi:10.1136/bmj.h68 · Cited by 288
Effect of Stimulants on Height and Weight: A Review of the Literature
Faraone, S. V., Biederman, J., Morley, C. P., & Spencer, T. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.obo13e31817eoea7 · Cited by 286
Pliszka, S. R., Glahn, D. C., Semrud-Clikeman, M., Franklin, C., Perez III, R., Xiong, J., & Liotti (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.1052 · Cited by 278 · cited 1×
“and those who had not, suggesting no lasting effect of treatment after wash-out [119,120].”
BackgroundBarkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2003) · Pediatrics · doi:10.1542/peds.111.1.97 · Cited by 274
Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder
Shaw, P., Sharp, W. S., Morrison, M., Eckstrand, K., Greenstein, D. K., Clasen, L. S., Evans, A. C., & Rapoport, J. L. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08050781 · Cited by 261 · cited 1×
“[99] found that over time, non-medicated adolescents with ADHD showed excessive cortical thinning compared to typically developing adolescents, whereas those who received stimulant medication did not.”
BackgroundTreatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review
Chan, E., Fogler, J. M., & Hammerness, P. G. (2016) · JAMA · doi:10.1001/jama.2016.5453 · Cited by 261 · cited 1×
“Although the shortterm evidence base of stimulants is well established [7,8], its long-term benefits are still unclear [9].”
BackgroundStiefel, G., & Besag, F. M. C. (2010) · Drug Safety · doi:10.2165/11536380-000000000-00000 · Cited by 257
Sudden Death and Use of Stimulant Medications in Youths
Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., Greenhill, L., & Cooper, T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040472 · Cited by 253
Konofal, E., Lecendreux, M., & Cortese, S. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.02.012 · Cited by 249
Stimulant Medications Precipitate Tourette's Syndrome
Lowe, T. L. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320370043028 · Cited by 248
Molina, B. S. G., Hinshaw, S. P., Eugene Arnold, L., Swanson, J. M., Pelham, W. E., Hechtman, L., Hoza, B., Epstein, J. N., Wigal, T., Abikoff, H. B., et al. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2012.12.014 · Cited by 246
CASTELLANOS, F. X., GIEDD, J. N., ELIA, J., MARSH, W. L., RITCHIE, G. F., HAMBURGER, S. D., & RAPOPORT, J. L. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199705000-00008 · Cited by 245
Assessment and Management of Sleep Problems in Youths With Attention-Deficit/Hyperactivity Disorder
Cortese, S., Brown, T. E., Corkum, P., Gruber, R., O’Brien, L. M., Stein, M., Weiss, M., & Owens, J. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.06.001 · Cited by 242
Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Grossman, S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.4.330 · Cited by 236
Stimulant Medication and Substance Use Outcomes: A Meta-analysis
Humphreys, K. L., Eng, T., & Lee, S. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1273 · Cited by 221 · cited 1×
“affect the development of SUDs or nicotine dependence [77].”
BackgroundGreven, C. U., Bralten, J., Mennes, M., O’Dwyer, L., van Hulzen, K. J. E., Rommelse, N., Schweren, L. J. S., Hoekstra, P. J., Hartman, C. A., Heslenfeld, D., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3162 · Cited by 198
Self-citationGarbarino, S., Lanteri, P., Durando, P., Magnavita, N., & Sannita, W. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13080831 · Cited by 197
Shafritz, K. M., Marchione, K. E., Gore, J. C., Shaywitz, S. E., & Shaywitz, B. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1990 · Cited by 190 · cited 1×
“patterns in children with ADHD [110,111] while at the same”
BackgroundEpstein, J. N., Casey, B. J., Tonev, S. T., Davidson, M. C., Reiss, A. L., Garrett, A., Hinshaw, S. P., Greenhill, L. L., Glover, G., Shafritz, K. M., et al. (2007) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2007.01761.x · Cited by 173
Morphological Abnormalities of the Thalamus in Youths With Attention Deficit Hyperactivity Disorder
Ivanov, I., Bansal, R., Hao, X., Zhu, H., Kellendonk, C., Miller, L., Sanchez-Pena, J., Miller, A. M., Chakravarty, M. M., Klahr, K., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030398 · Cited by 172
Rubia, K., Halari, R., Mohammad, A.-M., Taylor, E., & Brammer, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.018 · Cited by 171
Chen, Q., Sjolander, A., Runeson, B., D'Onofrio, B. M., Lichtenstein, P., & Larsson, H. (2014) · BMJ · doi:10.1136/bmj.g3769 · Cited by 170 · cited 1×
“If anything, the results pointed to a potential protective effect of methylphenidate on suicidal behavior [71].”
Ross, R. G. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.7.1149 · Cited by 167
Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD
Pliszka, S. R., Lancaster, J., Liotti, M., & Semrud-Clikeman, M. (2006) · Neurology · doi:10.1212/01.wnl.0000237385.84037.3c · Cited by 164
Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents
Schelleman, H., Bilker, W. B., Strom, B. L., Kimmel, S. E., Newcomb, C., Guevara, J. P., Daniel, G. W., Cziraky, M. J., & Hennessy, S. (2011) · Pediatrics · doi:10.1542/peds.2010-3371 · Cited by 159
Gilles de la Tourette's Syndrome following Methylphenidate Administration
Golden, G. S. (1974) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1974.tb02715.x · Cited by 148
Martínez-Raga, J., Knecht, C., Szerman, N., & Martínez, M. (2012) · CNS Drugs · doi:10.1007/s40263-012-0019-9 · Cited by 147
Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review
Westover, A. N., & Halm, E. A. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-41 · Cited by 140
Anderson, C. M., Polcari, A., Lowen, S. B., Renshaw, P. F., & Teicher, M. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1322 · Cited by 139
Tics following methylphenidate administration. A report of 20 cases
DENCKLA, M. B. (1976) · JAMA · doi:10.1001/jama.235.13.1349 · Cited by 137
Hinshaw, S. P., Arnold, L. E., & For the MTA Cooperative Group (2015) · WIREs Cognitive Science · doi:10.1002/wcs.1324 · Cited by 134
Mick, E., McManus, D. D., & Goldberg, R. J. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.011 · Cited by 134
The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?
Kaye, S., & Darke, S. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03720.x · Cited by 133
Stimulant medications and sleep for youth with ADHD: a meta-analysis
Kidwell, K. M., Van Dyk, T. R., Lundahl, A., & Nelson, T. D. (2015) · Pediatrics · doi:10.1542/peds.2015-1708 · Cited by 133
Attention-Deficit/Hyperactivity Disorder and Substance Abuse
Harstad, E., Levy, S., COMMITTEE ON SUBSTANCE ABUSE, Levy, S., Ammerman, S. D., Gonzalez, P. K., Ryan, S. A., Siqueira, L. M., & Smith, V. C. (2014) · Pediatrics · doi:10.1542/peds.2014-0992 · Cited by 131
Brain alterations in adult ADHD: Effects of gender, treatment and comorbid depression
Onnink, A. M. H., Zwiers, M. P., Hoogman, M., Mostert, J. C., Kan, C. C., Buitelaar, J., & Franke, B. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.011 · Cited by 131
Law, S., & Schachar, R. J. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199908000-00009 · Cited by 130
Awudu, G. A. H., & Besag, F. (2014) · Drug Safety · doi:10.1007/s40264-014-0201-8 · Cited by 126
Bledsoe, J., Semrud-Clikeman, M., & Pliszka, S. R. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.030 · Cited by 124
Markowitz, J. S., & Patrick, K. S. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140100-00004 · Cited by 123
Shin, J.-Y., Roughead, E. E., Park, B.-J., & Pratt, N. L. (2016) · BMJ · doi:10.1136/bmj.i2550 · Cited by 122
Dalsgaard, S., Kvist, A. P., Leckman, J. F., Nielsen, H. S., & Simonsen, M. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0020 · Cited by 121
Dalsgaard, S., Mortensen, P. B., Frydenberg, M., Maibing, C. M., Nordentoft, M., & Thomsen, P. H. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.06.004 · Cited by 121 · cited 1×
“for the later development of psychotic disorders [66] and that the link between methylphenidate and psychotic events may be limited to transient psychosis in susceptible individuals.”
Backgroundvan Lieshout, M., Luman, M., Twisk, J. W. R., van Ewijk, H., Groenman, A. P., Thissen, A. J. A. M., Faraone, S. V., Heslenfeld, D. J., Hartman, C. A., Hoekstra, P. J., et al. (2016) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-016-0820-y · Cited by 117
Self-citationGrowth of Hyperactive Children Treated With Methylphenidate
Satterfield, J. H. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780020102011 · Cited by 114
Gilles de la Tourette's syndrome: Tics and central nervous system stimulants in twins and nontwins
Price, R. A., Leckman, J. F., Pauls, D. L., Cohen, D. J., & Kidd, K. K. (1986) · Neurology · doi:10.1212/wnl.36.2.232 · Cited by 113
von Rhein, D., Cools, R., Zwiers, M. P., van der Schaaf, M., Franke, B., Luman, M., Oosterlaan, J., Heslenfeld, D. J., Hoekstra, P. J., Hartman, C. A., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.02.012 · Cited by 108 · cited 1×
“Individuals with ADHD show reduced activation of the striatum in response to reward [121].”
BackgroundSelf-citationBlood Pressure and Heart Rate Over 10 Years in the Multimodal Treatment Study of Children With ADHD
Vitiello, B., Elliott, G. R., Swanson, J. M., Arnold, L. E., Hechtman, L., Abikoff, H., Molina, B. S. G., Wells, K., Wigal, T., Jensen, P. S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10111705 · Cited by 106
Cohen, S. C., Mulqueen, J. M., Ferracioli-Oda, E., Stuckelman, Z. D., Coughlin, C. G., Leckman, J. F., & Bloch, M. H. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.06.011 · Cited by 105 · cited 2×
“However, these contraindications stem from anecdotal reports but are not backed by a recent meta-analysis [43].”
BackgroundKobel, M., Bechtel, N., Weber, P., Specht, K., Klarhöfer, M., Scheffler, K., Opwis, K., & Penner, I.-K. (2009) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2008.10.008 · Cited by 104
Konrad, K., Neufang, S., Fink, G. R., & Herpertz‐Dahlmann, B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318157cb3b · Cited by 102
Psychotic Side Effects of Psychostimulants: A 5-Year Review
Cherland, E., & Fitzpatrick, R. (1999) · The Canadian Journal of Psychiatry · doi:10.1177/070674379904400810 · Cited by 98
Gadow, K. D., Nolan, E. E., & Sverd, J. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199205000-00012 · Cited by 94
GADOW, K. D., NOLAN, E., SPRAFKIN, J., & SVERD, J. (1995) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-199506000-00004 · Cited by 94
Arns, M., van der Heijden, K. B., Arnold, L. E., & Kenemans, J. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.010 · Cited by 93 · cited 1×
“Complicating this relationship are the findings that medication-naive children with ADHD experience sleep problems as well [88], but also findings that show sleep problems can aggravate symptoms of ADHD and comorbid disorders [89] and even suggestions that sleep problems are at the base of ADHD [90].”
BackgroundADHD, Stimulant Treatment, and Growth: A Longitudinal Study
Harstad, E. B., Weaver, A. L., Katusic, S. K., Colligan, R. C., Kumar, S., Chan, E., Voigt, R. G., & Barbaresi, W. J. (2014) · Pediatrics · doi:10.1542/peds.2014-0428 · Cited by 92
Hammerness, P. G., Perrin, J. M., Shelley-Abrahamson, R., & Wilens, T. E. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.07.018 · Cited by 91
Stoy, M., Schlagenhauf, F., Schlochtermeier, L., Wrase, J., Knutson, B., Lehmkuhl, U., Huss, M., Heinz, A., & Ströhle, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2166-y · Cited by 91
Groenman, A. P., Oosterlaan, J., Rommelse, N. N. J., Franke, B., Greven, C. U., Hoekstra, P. J., Hartman, C. A., Luman, M., Roeyers, H., Oades, R. D., et al. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.124784 · Cited by 85
Self-citationBecker, S. P., Langberg, J. M., & Evans, S. W. (2015) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0636-6 · Cited by 82
McCabe, S. E., Dickinson, K., West, B. T., & Wilens, T. E. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.03.011 · Cited by 82 · cited 2×
“Factors that might enhance the protective effects of stimulant treatment on substance-related disorders include an earlier onset of stimulant use [78,79] and longer duration of stimulant use [79,80].”
BackgroundWong, C. G., & Stevens, M. C. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.11.011 · Cited by 80
Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence
Cunill, R., Castells, X., Tobias, A., & Capellà, D. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114544777 · Cited by 78 · cited 2×
“been done show an improvement in ADHD symptoms, but not in substance-related disorders [85].”
BackgroundSchrantee, A., Tamminga, H. G. H., Bouziane, C., Bottelier, M. A., Bron, E. E., Mutsaerts, H.-J. M. M., Zwinderman, A. H., Groote, I. R., Rombouts, S. A. R. B., Lindauer, R. J. L., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1572 · Cited by 77 · cited 1×
“[118] found that after a 1 week wash-out period, children with ADHD who had received 4 months of stimulant treatment”
BackgroundDopamine Inhibits Growth Hormone and Prolactin Secretion in the Human Newborn
de Zegher, F., den Berghe, G. V., Devlieger, H., Eggermont, E., & Veldhuis, J. D. (1993) · Pediatric Research · doi:10.1203/00006450-199311000-00016 · Cited by 77
Do stimulants provoke, cause, or exacerbate tics and tourette syndrome?
Shapiro, A. K., & Shapiro, E. (1981) · Comprehensive Psychiatry · doi:10.1016/0010-440x(81)90084-5 · Cited by 76
Shyu, Y., Yuan, S.-S., Lee, S.-Y., Yang, C.-J., Yang, K., Lee, T., & Wang, L. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.033 · Cited by 74
Gilles de la Tourette's Syndrome: Familial Occurrence and Precipitation By Methylphenidate Therapy
Pollack, M. A. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500220064011 · Cited by 74
Man, K. K. C., Coghill, D., Chan, E. W., Lau, W. C. Y., Hollis, C., Liddle, E., Banaschewski, T., McCarthy, S., Neubert, A., Sayal, K., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.216 · Cited by 70 · cited 1×
“This points to an association of psychotic events with ADHD symptoms rather than with methylphenidate [65].”
BackgroundEmergence of Tics in Children with ADHD: Impact of Once-Daily OROS® Methylphenidate Therapy
Palumbo, D., Spencer, T., Lynch, J., Co-Chien, H., & Faraone, S. V. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/1044546041649138 · Cited by 67 · cited 1×
“cantly different across those treated with osmotic-controlled release oral delivery system (OROS) methylphenidate, shortacting methylphenidate, or placebo [58].”
BackgroundKraemer, M., Uekermann, J., Wiltfang, J., & Kis, B. (2010) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181e29174 · Cited by 62
Are Psychostimulants a Treatment Option in Mania?
Hegerl, U., Sander, C., Olbrich, S., & Schoenknecht, P. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1220888 · Cited by 58
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis
Schoenfelder, E. N., Faraone, S. V., & Kollins, S. H. (2014) · Pediatrics · doi:10.1542/peds.2014-0179 · Cited by 55 · cited 1×
“While one meta-analysis reported a protective effect of stimulant treatment on the development of tobacco use [76], the other found that stimulant treatment did not”
ResultBereket, A., Turan, S., Karaman, M. G., Haklar, G., Ozbay, F., & Yazgan, M. Y. (2005) · Hormone Research in Paediatrics · doi:10.1159/000084683 · Cited by 53
Koneski, J. A. S., & Casella, E. B. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000100023 · Cited by 52
Koneski, J. A. S., Casella, E. B., Agertt, F., & Ferreira, M. G. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.02.029 · Cited by 51
Lee, M., Yang, K., Shyu, Y., Yuan, S.-S., Yang, C.-J., Lee, S.-Y., Lee, T., & Wang, L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.015 · Cited by 50
Wang, L., Shyu, Y., Yuan, S.-S., Yang, C.-J., Yang, K., Lee, T., & Lee, S.-Y. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.014 · Cited by 47
Gürkan, K., Bilgiç, A., Türkoğlu, S., Kılıç, B. G., Aysev, A., & Uslu, R. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109348172 · Cited by 44
The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children
(1977) · American Journal of Psychiatry · doi:10.1176/ajp.134.2.195 · Cited by 44
Batra, A. S., Alexander, M. E., & Silka, M. J. (2012) · Pediatric Cardiology · doi:10.1007/s00246-012-0162-6 · Cited by 42
Prehn‐Kristensen, A., Krauel, K., Hinrichs, H., Fischer, J., Malecki, U., Schuetze, H., Wolff, S., Jansen, O., Düzel, E., & Baving, L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.075 · Cited by 42
Hoekzema, E., Carmona, S., Ramos-Quiroga, J. A., Fernández, V. R., Picado, M., Bosch, R., Soliva, J. C., Rovira, M., Vives, Y., Bulbena, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048286 · Cited by 42
Eiland, L. S., Bell, E. A., & Erramouspe, J. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014541791 · Cited by 42
Semrud-Clikeman, M., Pliszka, S. R., Bledsoe, J., & Lancaster, J. (2014) · Journal of Attention Disorders · doi:10.1177/1087054712443158 · Cited by 40
Schweren, L., Hartman, C. A., Heslenfeld, D. J., van der Meer, D., Franke, B., Oosterlaan, J., Buitelaar, J. K., Faraone, S. V., & Hoekstra, P. J. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.05.014 · Cited by 38
Self-citationStimulant medications precipitate Tourette's syndrome
Lowe, T. L. (1982) · JAMA · doi:10.1001/jama.247.12.1729 · Cited by 37
Psychopharmacological Prescriptions in Children and Adolescents in Germany
Abbas, S., Ihle, P., Adler, J., Engel, S., Günster, C., Linder, R., Lehmkuhl, G., & Schübert, I. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0396 · Cited by 36
Barkla, X. M., McArdle, P., & Newbury‐Birch, D. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0657-9 · Cited by 35
Sheridan, M. A., Hinshaw, S., & D'Esposito, M. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709347444 · Cited by 34
Stimulant Medication and Psychotic Symptoms in Offspring of Parents With Mental Illness
MacKenzie, L. E., Abidi, S., Fisher, H. L., Propper, L., Bagnell, A. L., Morash-Conway, J., Glover, J. M., Cumby, J., Hájek, T., Schultze‐Lutter, F., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2486 · Cited by 32
Methylphenidate-induced Tourette syndrome: case report
Bremness, A., & Sverd, J. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.10.1334 · Cited by 32
Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
Hammerness, P. G., Karampahtsis, C., Babalola, R., & Alexander, M. E. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1011620 · Cited by 30
Santisteban, J. A., Stein, M. A., Bergmame, L., & Gruber, R. (2014) · CNS Drugs · doi:10.1007/s40263-014-0181-3 · Cited by 29
Prescription stimulant use is associated with earlier onset of psychosis
Moran, L. V., Masters, G. A., Pingali, S. M., Cohen, B. M., Liebson, E. S., Rajarethinam, R., & Öngür, D. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.09.012 · Cited by 25
Lee, Y.-S., Han, D. H., Lee, J. H., & Choi, T. Y. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.1.49 · Cited by 24
Challis (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6873 · Cited by 23
Ravi, M., & Ickowicz, A. (2016) · PubMed · Cited by 23
Kovshoff, H., Banaschewski, T., Buitelaar, J. K., Carucci, S., Coghill, D., Danckaerts, M., Dittmann, R., Falissard, B., Gojković, D., Hollis, C. P., et al. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0218 · Cited by 22
Winterstein, A. G. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0379-y · Cited by 19
Mazza, M., D'Ascenzo, F., Davico, C., Biondi-Zoccai, G., Frati, G., Romagnoli, E., Bassi, B., Janiri, L., Moretti, C., & Gaita, F. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.04.169 · Cited by 18
Schweren, L., Groenman, A. P., von Rhein, D. T., Weeda, W. D., Faraone, S. V., Luman, M., van Ewijk, H., Heslenfeld, D. J., Franke, B., Buitelaar, J. K., et al. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10624 · Cited by 14
Self-citationSchweren, L., Hartman, C. A., Heslenfeld, D. J., Groenman, A. P., Franke, B., Oosterlaan, J., Buitelaar, J. K., & Hoekstra, P. J. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.06.013 · Cited by 12
Self-citationAntel, J., Albayrak, Ö., Heusch, G., Banaschewski, T., & Hebebrand, J. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0522-8 · Cited by 11
Fear of Stimulant Therapy for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Johnson, M. R. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0117 · Cited by 5
Bluschke, A., von der Hagen, M., Novotna, B., Roessner, V., & Beste, C. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00092 · Cited by 3
Research works printed but not linked: 5
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders [DSM-IV-TR]. Washington (DC): American Psychiatric Association; 2000.
- Storebo OJ, Ramstad E, Krogh HB, et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. 2015 Nov 25;(11):Cd009885. Epub 2015 Nov 26.
- Johnson MR. Increased cardiovascular risk associated with methylphenidate use in children and adolescents with ADHD? Examine the evidence. BMJ. 2016;353:i2550. [letter to the editor]
- 10.1001/jama.1976.03260390035024 · doi:10.1001/jama.1976.03260390035024 · Paper page
- 10.1176/appi.ajp.163.7.1149 · doi:10.1176/appi.ajp.163.7.1149 · Paper page
Cited by
Treatment strategies for ADHD: an evidence-based guide to select optimal treatment
Caye, A., Swanson, J. M., Coghill, D., & Rohde, L. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0116-3 · Cited by 303
Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts
Chang, Z., Quinn, P. D., O’Reilly, L. M., Sjölander, A., Hur, K., Gibbons, R. D., Larsson, H., & D'Onofrio, B. M. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.12.003 · Cited by 71
Pozzi, M., Carnovale, C., Peeters, G. G. A. M., Gentili, M., Antoniazzi, S., Radice, S., Clementi, E., & Nobile, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.05.021 · Cited by 56
Rosi, E., Grazioli, S., Villa, F. M., Mauri, M., Gazzola, E., Pozzi, M., Molteni, M., & Nobile, M. (2020) · Nutrients · doi:10.3390/nu12061573 · Cited by 27
Lionarons, J. M., Hellebrekers, D. M. J., Klinkenberg, S., Faber, C. G., Vles, J. S. H., & Hendriksen, J. G. M. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.09.005 · Cited by 20
Metadata
- Authors
- Groenman, A. P., Schweren, L. J. S., Dietrich, A., & Hoekstra, P. J.
- Affiliations
- University Medical Center Groningen (NL)
- University of Cambridge (GB)
- Corresponding author
- Groenman, Annabeth P.
- Venue
- Expert Opinion on Drug Safety
- Publisher
- Informa UK Limited
- Published
- 2017-03-09
- Volume
- 16
- Issue
- 4
- Pages
- 455-464
- ISSN
- 1474-0338 (ISSN-L)
- 1744-764X
- OpenAlex
- W2592348399
- Cited by
- 46
- References
- 123
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 3
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- green
- research.rug.nl
- Licence
- other-oa
- Locations
- Expert Opinion on Drug Safety (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- attention deficit hyperactivity disorder, methylphenidate, psychostimulants, drug safety, long-term efficacy, sleep disorders, growth reduction, appetite loss, psychiatric adverse events, brain development
- MeSH terms
- Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Brain, Humans, Methylphenidate, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.